17don MSN
Structure Therapeutics details positive trial data for a weight-loss pill, and the stock rockets
Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron that just showed positive results from a Phase 2 trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback